Quantcast

Pfizer Board Member Scott Gottlieb Pressured Twitter to Censor Vaccine Criticism

REDSTATE – In the latest edition of the Twitter Files, journalist Alex Berenson revealed the lengths that people in power went to in order to make sure that the party line was maintained – and Twitter went right along with it.

But, this wasn’t just government censorship. This was a private company with a financial interest in its COVID vaccine wanting itself to be inoculated from criticism.

Dr. Scott Gottleib, who is on the board for the pharmaceutical giant Pfizer, is a former FDA commissioner, and he used his influence to get Twitter to silence dissent against his company’s COVID-19 vaccine.

Among other deeply problematic files, Berenson revealed that, in an August 2021 email, Gottlieb flagged a tweet written by former Trump administration official Dr. Brett Giroir.

The email was sent to Twitter’s senior public policy manager Todd O’Boyle. Giroir’s tweet said “It’s now clear #COVID19 natural immunity is superior to #vaccine immunity, by ALOT. There’s no scientific justification for #vax proof if a person had prior infection.”

...article continued below
- Advertisement -

Berenson broke down just how the tweet ended up getting flagged.

The post was “corrosive,” Gottlieb wrote. He worried it would “end up going viral and driving news coverage.”

Through Jira, an internal system Twitter used for managing complaints, O’Boyle forwarded Gottlieb’s email to the Twitter “Strategic Response” team. That group was responsible for handling concerns from the company’s most important employees and users.

“Please see this report from the former FDA commissioner,” O’Boyle wrote – failing to mention that Gottlieb was a Pfizer board member with a financial interest in pushing mRNA shots.

A Strategic Response analyst quickly found the tweet did not violate any of the company’s misinformation rules.

...article continued below
- Advertisement -

Yet Twitter wound up flagging Giroir’s tweet anyway, putting a misleading tag on it … read more. 

 

- Advertisement -
- Advertisement -
- Advertisement -

TRENDING

- Advertisement -
- Advertisement -